Skip to main content
Erschienen in: Supportive Care in Cancer 4/2011

01.04.2011 | Original Article

Complementary and alternative medicine: use and disclosure in radiation oncology community practice

verfasst von: Sarah M. Rausch, Frankie Winegardner, Kelly M. Kruk, Vaishali Phatak, Dietlind L. Wahner-Roedler, Brent Bauer, Ann Vincent

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aims of this study were to evaluate the frequency of complementary and alternative medicine (CAM) use among radiation oncology patients, the coping strategies that influenced this use, and the rates of disclosure of CAM use to their healthcare providers.

Methods

One hundred fifty-three patients undergoing radiation therapy for various neoplasms at rural cancer centers in Minnesota completed the Mayo Complementary and Alternative Medicine Use Survey and the Coping Inventory for Stressful Situations questionnaires. Data regarding CAM use was also compared with provider consultation notes in the medical record at the onset of radiation therapy to determine rates of patient disclosure of CAM use to their healthcare providers.

Results

A total of 153 participants completed the study with 61.4% females and 38.6% males and a mean age of 64.9 years. The two most frequent diagnoses of participants were breast cancer (43.8%) and prostate cancer (22.9%). CAM use was reported in 95% of the participants and was categorized into three domains: treatments and techniques, vitamins, and herbs and supplements. The three most frequently reported treatments and techniques were spiritual healing/prayer (62.1%), exercise (19.6%), and music (17.6%). The top three most frequently used biologically based CAM therapies were multivitamins (48.1%), calcium (37.3%), and vitamin with minerals (21.5%). The most frequently used herbs and other dietary supplements were fish oil (19.0%), flaxseed (15.0%), glucosamine (15.0%), and green tea (15.0%). The most common reason cited for CAM treatments and techniques use was previous use (26.1%), for use of vitamins and minerals was recommendation by a physician (33.0%), and for use of herbs and other supplements was previous use (19.0%). One hundred twelve participants reported taking vitamins, minerals, or supplements, and 47% of those 112 did not disclose this use to their providers.

Conclusions

Consistent with previous research, our study found that the majority of cancer patients used CAM treatments. Spiritual healing/prayer was the most commonly reported, followed by multivitamins. Patients reported using CAM primarily due to previous use and physician recommendation. Unfortunately, disclosure of CAM use to healthcare providers was relatively low.
Literatur
2.
Zurück zum Zitat Nahin RL, Barnes PM, Stussman BJ, Bloom B (2009) Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. National health statistics reports; no 18. National Center for Health Statistics, Hyattsville, MD Nahin RL, Barnes PM, Stussman BJ, Bloom B (2009) Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. National health statistics reports; no 18. National Center for Health Statistics, Hyattsville, MD
3.
Zurück zum Zitat Barnes PM, Bloom B, Nahin R (2007) CDC National Health Statistics Report #12. Complementary and alternative medicine use among adults and children: United States, December 10, 2008 Barnes PM, Bloom B, Nahin R (2007) CDC National Health Statistics Report #12. Complementary and alternative medicine use among adults and children: United States, December 10, 2008
4.
Zurück zum Zitat Gross AM, Liu QL, Bauer-Wu S (2007) Prevalence and predictors of complementary therapy use in advanced-stage breast cancer patients. J Oncol Pract 3(6):292–295PubMedCrossRef Gross AM, Liu QL, Bauer-Wu S (2007) Prevalence and predictors of complementary therapy use in advanced-stage breast cancer patients. J Oncol Pract 3(6):292–295PubMedCrossRef
5.
Zurück zum Zitat Burstein H, Gelber S, Guadagnoli E et al (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340(22):1733–1739PubMedCrossRef Burstein H, Gelber S, Guadagnoli E et al (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340(22):1733–1739PubMedCrossRef
6.
Zurück zum Zitat Matthews AK, Sellergren SA, Huo D, List M, Fleming G (2007) Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med 13(5):555–562PubMedCrossRef Matthews AK, Sellergren SA, Huo D, List M, Fleming G (2007) Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med 13(5):555–562PubMedCrossRef
7.
Zurück zum Zitat Barnes PM, Powell-Griner E, McFann K, Nahin RL (2004) Complementary and alternative medicine use among adults: United States, 2002. Adv Data 343:1–19PubMed Barnes PM, Powell-Griner E, McFann K, Nahin RL (2004) Complementary and alternative medicine use among adults: United States, 2002. Adv Data 343:1–19PubMed
8.
Zurück zum Zitat Mao JJ, Farrar JT, Xie SX, Bowman MA, Armstrong K (2007) Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer. Complement Ther Med 15(1):21–29PubMedCrossRef Mao JJ, Farrar JT, Xie SX, Bowman MA, Armstrong K (2007) Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer. Complement Ther Med 15(1):21–29PubMedCrossRef
9.
Zurück zum Zitat Cassileth BR, Deng G (2004) Complementary and alternative therapies for cancer. Oncologist 9:80–89PubMedCrossRef Cassileth BR, Deng G (2004) Complementary and alternative therapies for cancer. Oncologist 9:80–89PubMedCrossRef
10.
Zurück zum Zitat Yates JS, Mustian KM, Morrow GR (2005) Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer 13(10):806–811PubMedCrossRef Yates JS, Mustian KM, Morrow GR (2005) Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer 13(10):806–811PubMedCrossRef
11.
Zurück zum Zitat Mollasiotis A, Yung HP, Yam BM, Chan FY, Mok TS (2002) The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomised controlled trial. Support Care Cancer 10(3):237–246CrossRef Mollasiotis A, Yung HP, Yam BM, Chan FY, Mok TS (2002) The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomised controlled trial. Support Care Cancer 10(3):237–246CrossRef
12.
Zurück zum Zitat Sahler OJ, Hunter BC, Liesveld JL (2003) The effect of using music therapy with relaxation imagery in the management of patients undergoing bone marrow transplantation: a pilot feasibility study. Altern Ther Health Med 9(6):70–74PubMed Sahler OJ, Hunter BC, Liesveld JL (2003) The effect of using music therapy with relaxation imagery in the management of patients undergoing bone marrow transplantation: a pilot feasibility study. Altern Ther Health Med 9(6):70–74PubMed
13.
Zurück zum Zitat Syrjala KL (1995) Relaxation and imagery and cognitive–behavioral training reduce pain during cancer treatment: a controlled clinical trial. Pain 63(2):189–198PubMedCrossRef Syrjala KL (1995) Relaxation and imagery and cognitive–behavioral training reduce pain during cancer treatment: a controlled clinical trial. Pain 63(2):189–198PubMedCrossRef
14.
Zurück zum Zitat Jarden M, Hovgaard D, Boesne E, Quist M, Adamsen L (2007) Pilot study of a multimodal intervention: mixed-type exercise and psychoeducation in patients undergoing allogeneic stem cell transplantation. Bone Marrow Transplant 40(8):793–800PubMedCrossRef Jarden M, Hovgaard D, Boesne E, Quist M, Adamsen L (2007) Pilot study of a multimodal intervention: mixed-type exercise and psychoeducation in patients undergoing allogeneic stem cell transplantation. Bone Marrow Transplant 40(8):793–800PubMedCrossRef
15.
Zurück zum Zitat Horton Deutsch S, O'Haverday P, Haight R, Babin-Nelson M (2007) Enhancing mental health services to bone marrow transplant recipients through a mindfulness-based therapeutic intervention. Complement Ther Clin Pract 13(2):110–115PubMedCrossRef Horton Deutsch S, O'Haverday P, Haight R, Babin-Nelson M (2007) Enhancing mental health services to bone marrow transplant recipients through a mindfulness-based therapeutic intervention. Complement Ther Clin Pract 13(2):110–115PubMedCrossRef
16.
Zurück zum Zitat Holland JC, Morrow GR, Schmale A, Derogatis L, Stefanek M, Berenson S, Carpenter PJ, Breitbart W, Feldstein M (1991) A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J Clin Oncol 9(6):1004–1011PubMed Holland JC, Morrow GR, Schmale A, Derogatis L, Stefanek M, Berenson S, Carpenter PJ, Breitbart W, Feldstein M (1991) A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J Clin Oncol 9(6):1004–1011PubMed
17.
Zurück zum Zitat Kim SD, Kim HS (2005) Effects of a relaxation breathing exercise on anxiety, depression, and leukocyte in hemopoietic stem cell transplantation patients. Cancer Nurs 28(1):79–83PubMedCrossRef Kim SD, Kim HS (2005) Effects of a relaxation breathing exercise on anxiety, depression, and leukocyte in hemopoietic stem cell transplantation patients. Cancer Nurs 28(1):79–83PubMedCrossRef
18.
Zurück zum Zitat Kim SD, Kim HS (2005) Effects of a relaxation breathing exercise on fatigue in haemopoietic stem cell transplantation patients. J Clin Nurs 14(1):51–55PubMedCrossRef Kim SD, Kim HS (2005) Effects of a relaxation breathing exercise on fatigue in haemopoietic stem cell transplantation patients. J Clin Nurs 14(1):51–55PubMedCrossRef
19.
Zurück zum Zitat Cohen L, Warneke C, Fouladi RT, Rodriguez MA, Chaoul-Reich A (2004) Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer 100(10):2253–2260PubMedCrossRef Cohen L, Warneke C, Fouladi RT, Rodriguez MA, Chaoul-Reich A (2004) Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer 100(10):2253–2260PubMedCrossRef
20.
Zurück zum Zitat Hardy ML (2008) Dietary supplement use in cancer care: help or harm. Hematol Oncol Clin North Am 22(4):581–617PubMedCrossRef Hardy ML (2008) Dietary supplement use in cancer care: help or harm. Hematol Oncol Clin North Am 22(4):581–617PubMedCrossRef
21.
Zurück zum Zitat Hensel M, Zoz M, Ho AD (2009) Complementary and alternative medicine in patients with chronic lymphocytic leukemia. Support Care Cancer 17:47–52PubMedCrossRef Hensel M, Zoz M, Ho AD (2009) Complementary and alternative medicine in patients with chronic lymphocytic leukemia. Support Care Cancer 17:47–52PubMedCrossRef
22.
Zurück zum Zitat Perez-Cruz I, Carcamo JM, Golde DW (2003) Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells. Blood 102:336–343PubMedCrossRef Perez-Cruz I, Carcamo JM, Golde DW (2003) Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells. Blood 102:336–343PubMedCrossRef
23.
Zurück zum Zitat Perez-Cruz I, Carcamo JM, Golde DW (2007) Caspase-8 dependent trail-induced apoptosis in cancer cell lines is inhibited by vitamin C and catalase. Apoptosis 12:225–234PubMedCrossRef Perez-Cruz I, Carcamo JM, Golde DW (2007) Caspase-8 dependent trail-induced apoptosis in cancer cell lines is inhibited by vitamin C and catalase. Apoptosis 12:225–234PubMedCrossRef
24.
Zurück zum Zitat Werneke U, Earl J, Seydel C, Horn O, Crichton P, Fannon D (2004) Potential health risks of complementary and alternative medicine in cancer patients. Br J Cancer 90(2):408–413PubMedCrossRef Werneke U, Earl J, Seydel C, Horn O, Crichton P, Fannon D (2004) Potential health risks of complementary and alternative medicine in cancer patients. Br J Cancer 90(2):408–413PubMedCrossRef
25.
Zurück zum Zitat Skalli S, Zaid A, Soulaymani R (2007) Drug interactions with herbal medicines. Ther Drug Monit 29(6):679–686PubMedCrossRef Skalli S, Zaid A, Soulaymani R (2007) Drug interactions with herbal medicines. Ther Drug Monit 29(6):679–686PubMedCrossRef
26.
Zurück zum Zitat Kumar NB, Allen K, Bell H (2005) Perioperative herbal supplement use in cancer patients: potential implications and recommendations for presurgical screening. Cancer Control 12(3):149–157PubMed Kumar NB, Allen K, Bell H (2005) Perioperative herbal supplement use in cancer patients: potential implications and recommendations for presurgical screening. Cancer Control 12(3):149–157PubMed
27.
Zurück zum Zitat Sparreboom A, Cox MC, Acharya MR, Figg WD (2004) Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 22:2489–2503PubMedCrossRef Sparreboom A, Cox MC, Acharya MR, Figg WD (2004) Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 22:2489–2503PubMedCrossRef
28.
Zurück zum Zitat Robinson A, McGrail MR (2004) Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med 12(2–3):90–98PubMedCrossRef Robinson A, McGrail MR (2004) Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med 12(2–3):90–98PubMedCrossRef
29.
Zurück zum Zitat Powell CB, Dibble SL, Dall'Era JE, Cohen I (2002) Use of herbs in women diagnosed with ovarian cancer. Int J Gynecol Cancer 12:214–217PubMedCrossRef Powell CB, Dibble SL, Dall'Era JE, Cohen I (2002) Use of herbs in women diagnosed with ovarian cancer. Int J Gynecol Cancer 12:214–217PubMedCrossRef
30.
Zurück zum Zitat Balneaves LG, Kristjanson LJ, Tataryn D (1999) Beyond convention: describing complementary therapy use by women living with breast cancer. Patient Educ Couns 38:143–153PubMedCrossRef Balneaves LG, Kristjanson LJ, Tataryn D (1999) Beyond convention: describing complementary therapy use by women living with breast cancer. Patient Educ Couns 38:143–153PubMedCrossRef
31.
Zurück zum Zitat Nam RK, Fleshner N, Rakovitch E, Klotz L, Trachtenberg J, Choo R et al (1999) Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis. J Urol 161:1521–1524PubMedCrossRef Nam RK, Fleshner N, Rakovitch E, Klotz L, Trachtenberg J, Choo R et al (1999) Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis. J Urol 161:1521–1524PubMedCrossRef
32.
Zurück zum Zitat Adler SR, Fosket JR (1999) Disclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer. J Fam Pract 48:453–458PubMed Adler SR, Fosket JR (1999) Disclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer. J Fam Pract 48:453–458PubMed
33.
Zurück zum Zitat Wahner-Roedler DL, Elkin PL, Lee MC, Vincent A, Gay R, Loehrer LL, Pankratz VS, Bauer BA (2004) Complementary and alternative medicine: use by patients seen in different specialty areas in a tertiary-care center. Evid Based Integr Med 1(4):253–260CrossRef Wahner-Roedler DL, Elkin PL, Lee MC, Vincent A, Gay R, Loehrer LL, Pankratz VS, Bauer BA (2004) Complementary and alternative medicine: use by patients seen in different specialty areas in a tertiary-care center. Evid Based Integr Med 1(4):253–260CrossRef
34.
Zurück zum Zitat Wahner-Roedler DL, Elkin PL, Vincent A, Thompson JM, Oh TH, Loehrer LL et al (2005) Use of complementary and alternative medical therapies by patients referred to a fibromyalgia treatment program at a tertiary care center. Mayo Clin Proc 80:55–60PubMedCrossRef Wahner-Roedler DL, Elkin PL, Vincent A, Thompson JM, Oh TH, Loehrer LL et al (2005) Use of complementary and alternative medical therapies by patients referred to a fibromyalgia treatment program at a tertiary care center. Mayo Clin Proc 80:55–60PubMedCrossRef
36.
Zurück zum Zitat Endler NS, Parker JD (1990) Coping inventory for stressful situations: manual, 2nd edn. Multi-Health Systems, North Tonawanda Endler NS, Parker JD (1990) Coping inventory for stressful situations: manual, 2nd edn. Multi-Health Systems, North Tonawanda
37.
Zurück zum Zitat Cosway R, Endler N (2000) The Coping Inventory for Stressful Situations: factorial structure and associations with personality traits and psychological health. J Appl Biobehav Res 5(2):121–143CrossRef Cosway R, Endler N (2000) The Coping Inventory for Stressful Situations: factorial structure and associations with personality traits and psychological health. J Appl Biobehav Res 5(2):121–143CrossRef
38.
Zurück zum Zitat Kurokawa NK, Weed NC (1998) Interrater agreement on the Coping Inventory for Stressful Situations (CISS). Assessment 5(1):93–100PubMedCrossRef Kurokawa NK, Weed NC (1998) Interrater agreement on the Coping Inventory for Stressful Situations (CISS). Assessment 5(1):93–100PubMedCrossRef
39.
Zurück zum Zitat Kumano H, Haseme E, Fujimoto H et al (2005) Harmony seeking and the risk of prostate cancer: a prebioptic study. J Psychosom Res 59(3):167–174PubMedCrossRef Kumano H, Haseme E, Fujimoto H et al (2005) Harmony seeking and the risk of prostate cancer: a prebioptic study. J Psychosom Res 59(3):167–174PubMedCrossRef
40.
Zurück zum Zitat McWilliams LA, Cox BJ, Enns MW (2003) Use of the Coping Inventory for Stressful Situations in a clinically depressed sample: factor structure, personality correlates, and prediction of distress. J Clin Psychol 59(4):423–437PubMedCrossRef McWilliams LA, Cox BJ, Enns MW (2003) Use of the Coping Inventory for Stressful Situations in a clinically depressed sample: factor structure, personality correlates, and prediction of distress. J Clin Psychol 59(4):423–437PubMedCrossRef
41.
Zurück zum Zitat Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18:2505–2514PubMed Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18:2505–2514PubMed
42.
Zurück zum Zitat Ernst E, Cassileth BR (1998) The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 83(4):777–782PubMedCrossRef Ernst E, Cassileth BR (1998) The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 83(4):777–782PubMedCrossRef
43.
Zurück zum Zitat The Gallupp Organization (2003) The Gallupp poll: public opinion 2002. Scholarly Resources Inc., Wilmington, p 257 The Gallupp Organization (2003) The Gallupp poll: public opinion 2002. Scholarly Resources Inc., Wilmington, p 257
44.
Zurück zum Zitat Vapiwala N, Mick R et al (2006) Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer J 12(6):467–474PubMedCrossRef Vapiwala N, Mick R et al (2006) Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer J 12(6):467–474PubMedCrossRef
Metadaten
Titel
Complementary and alternative medicine: use and disclosure in radiation oncology community practice
verfasst von
Sarah M. Rausch
Frankie Winegardner
Kelly M. Kruk
Vaishali Phatak
Dietlind L. Wahner-Roedler
Brent Bauer
Ann Vincent
Publikationsdatum
01.04.2011
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2011
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-010-0846-5

Weitere Artikel der Ausgabe 4/2011

Supportive Care in Cancer 4/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.